Safety and efficacy of BI 695501 versus adalimumab reference product in patients with advanced Crohn's disease (VOLTAIRE-CD): a multicentre, randomised, double-blind, phase 3 trial
Stephen B. Hanauer, Bernd Liedert, Sigrid Balser, Ekkehard Brockstedt, Viktoria Moschetti, Stefan Schreiber
Topics & Concepts
AdalimumabMedicineClinical endpointInternal medicineCrohn's diseaseInfliximabPsoriasis Area and Severity IndexAdverse effectRheumatoid arthritisRandomized controlled trialPlaceboPsoriasisClinical trialGastroenterologyDiseaseDermatologyAlternative medicinePathologyBiosimilars and Bioanalytical MethodsInflammatory Bowel DiseaseRheumatoid Arthritis Research and Therapies